← Back to NON RARE IN EUROPE: Rheumatoid arthritis

NON RARE IN EUROPE: Rheumatoid arthritis

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Jun 2026DEXA Bone Density Analysis of the CoreHip® Prosthesis System

Aesculap AG — NA

TrialNOT YET RECRUITING
Mar 2026QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis

Qilu Pharmaceutical Co., Ltd. — PHASE2

TrialNOT YET RECRUITING
Mar 2026Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)

Sohag University

TrialNOT YET RECRUITING
Feb 2026Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD

Changchun GeneScience Pharmaceutical Co., Ltd. — PHASE2

TrialNOT YET RECRUITING
Feb 2026Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Seismic Therapeutic AU Pty Ltd — PHASE1

TrialNOT YET RECRUITING
Jan 2026Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases

Bursa City Hospital

TrialNOT YET RECRUITING
Jan 2026Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis

Tanta University — PHASE4

TrialNOT YET RECRUITING
Dec 2025Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations and Immune Infiltrate Characterization : the UTOPIC Project

University Hospital, Brest — NA

TrialNOT YET RECRUITING
Dec 2025A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

Hoffmann-La Roche — PHASE2

TrialRECRUITING
Oct 2025The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

Guangdong Hengrui Pharmaceutical Co., Ltd — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for NON RARE IN EUROPE: Rheumatoid arthritis.
Check the disease page for updates →

Clinical Trial Landscape

31 active trials
2Phase 3
1Phase 4
5Phase 2
6Phase 1
7N/A
9Unknown
1PHASE1, PHASE2
31Total recruiting
Search clinical trials for NON RARE IN EUROPE: Rheumatoid arthritis

Recent News & Research

No recent news articles indexed yet for NON RARE IN EUROPE: Rheumatoid arthritis.
Search PubMed for NON RARE IN EUROPE: Rheumatoid arthritis

Browse all NON RARE IN EUROPE: Rheumatoid arthritis news →

Specialist Network

No specialists currently listed for NON RARE IN EUROPE: Rheumatoid arthritis.

View all NON RARE IN EUROPE: Rheumatoid arthritis specialists →

Quick Actions